K-Ras activates the mTORC1/SREBPs (SREBP1 and SREBP2) signaling pathway and enhances the autonomous growth of breast cancer cells by activating Erk with minimal activation of Akt (Ricoult et al., 2016). Here, SREBF2 is linked to breast carcinoma.